Evidence map›Paper›PMID 42032960›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026

[miR-34a targets MTUS1 to regulate cardiac fibrosis in rats].

Jiajia Hu, Xiaoxu Lu, Jianqin Yan, Zhongshang Xie, Junjie Zhang, Chengliang Zhang

Abstract readEnglish Abstract
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiajia HuDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008. doctor7hjj@csu.edu.cn.
Xiaoxu LuDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008.
Jianqin YanDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008.
Zhongshang XieNational Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha 410008.
Junjie ZhangDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008.
Chengliang ZhangNational Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha 410008. zhangchengliang@csu.edu.cn.

Funding

the Changsha Natural Science Foundation kq2403005
6 · The paper itself

Abstract

objectivesCardiac fibrosis is a common pathological feature during the progression of various cardiovascular diseases and is characterized by excessive deposition of extracellular matrix (ECM) in the myocardial interstitium, accompanied by alterations in cardiac structure and function. MicroRNAs (miRNAs) play important roles in the regulation of cardiac fibrosis. Previous studies have suggested that miR-34a is involved in fibrotic processes; however, its in vivo effects on cardiac fibrosis and cardiac function, as well as its relationship with mitochondrial tumor suppressor 1 (MTUS1), remain unclear. This study aimed to investigate the effects of miR-34a targeting MTUS1 on cardiac fibrosis and cardiac function in rats through in vivo intervention.

methodsHealthy adult male Sprague-Dawley (SD) rats were used to establish a myocardial fibrosis model by subcutaneous injection of isoproterenol (ISO) at a dose of 10 mg/(kg·d) for 14 consecutive days (model group), while the control group received equal volumes of normal saline. Transthoracic echocardiography (TTE) was performed to evaluate cardiac structural and functional changes. Left ventricular tissues were collected and paraffin sections were prepared. Hematoxylin-eosin (HE) staining was used to observe histological changes in myocardial tissue, and Masson staining was used to assess collagen deposition. Real-time polymerase chain reaction (real-time PCR) and Western blotting were performed to detect the expression levels of miR-34a, MTUS1, and fibrosis-related proteins including α-smooth muscle actin (α-SMA) and collagen I. Bioinformatics analysis was used to predict potential binding sites between miR-34a and MTUS1. A dual-luciferase reporter assay was performed to verify the targeting relationship between miR-34a and MTUS1. Furthermore, adeno-associated virus (AAV) was used in vivo to downregulate the expression of miR-34a and MTUS1, and the effects on cardiac function and myocardial fibrosis were evaluated.

resultsISO-treated rats exhibited pronounced myocardial fibrotic changes. HE staining revealed disorganized myocardial fibers and widened interstitial spaces, and Masson staining demonstrated increased collagen deposition. TTE analysis showed that left ventricular ejection fraction was reduced in the model group compared with the control group (

conclusionsIn an ISO-induced rat model of cardiac fibrosis, miR-34a participates in the regulation of myocardial fibrosis and cardiac functional alterations by targeting MTUS1. The in vivo AAV intervention results suggest that the miR-34a-MTUS1 regulatory axis is associated with the progression of cardiac fibrosis.

Indexed as

MicroRNAsMyocardiumTumor Suppressor ProteinsAnimalsFibrosisIsoproterenolMaleRatsRats, Sprague-DawleyIsoproterenolMicroRNAsMIRN34 microRNA, ratTumor Suppressor Proteinsadeno-associated viruscardiac fibrosiscardiac functionmiR-34amitochondrial tumor suppressor 1transthoracic echocardiography

Identifiers

PMID42032960
PMCPMC13071599

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.